American Healthcare REIT (NYSE:AHR) Hits New 12-Month High – Here’s What Happened

Posted by Stanley Muller on Nov 11th, 2026

American Healthcare REIT, Inc. (NYSE:AHR – Get Free Report)’s share price hit a new 52-week high on Monday. The stock traded as high as $58.79 and last traded at $58.5460, with a volume of 1,077,160 shares trading hands. The stock had previously closed at $57.91.

Analyst Ratings Changes

A number of research firms recently weighed in on AHR. Scotiabank upped their price target on American Healthcare REIT from $56.00 to $62.00 and gave the stock an “outperform” rating in a report on Wednesday, September 2nd. Barclays dropped their price objective on American Healthcare REIT from $66.00 to $60.00 and set an “overweight” rating on the stock in a report on Tuesday, October 13th. Citizens Jmp boosted their price objective on American Healthcare REIT from $60.00 to $65.00 and gave the company a “market outperform” rating in a research report on Monday, July 27th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $72.00 target price on shares of American Healthcare REIT in a research note on Tuesday. Finally, KeyCorp increased their target price on American Healthcare REIT from $58.00 to $68.00 and gave the company an “overweight” rating in a research report on Wednesday, August 19th. Two equities research analysts have rated the stock with a Strong Buy rating and thirteen have assigned a Buy rating to the stock. According to data from MarketBeat, American Healthcare REIT currently has a consensus rating of “Buy” and an average target price of $63.31.

Get Our Latest Research Report on American Healthcare REIT

American Healthcare REIT Stock Down 0.3%

The company has a current ratio of 0.53, a quick ratio of 0.48 and a debt-to-equity ratio of 0.15. The business has a fifty day simple moving average of $53.24 and a two-hundred day simple moving average of $51.76. The company has a market cap of $12.91 billion, a PE ratio of 120.77, a price-to-earnings-growth ratio of 1.40 and a beta of 0.78.

American Healthcare REIT (NYSE:AHR – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.02. The firm had revenue of $742.15 million for the quarter, compared to the consensus estimate of $703.51 million. American Healthcare REIT had a net margin of 3.61% and a return on equity of 2.38%. The company’s revenue for the quarter was up 29.5% on a year-over-year basis. During the same period last year, the firm posted $0.44 earnings per share. As a group, equities research analysts predict that American Healthcare REIT, Inc. will post 2.25 earnings per share for the current year.

American Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 16th. Shareholders of record on Wednesday, September 30th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Wednesday, September 30th. American Healthcare REIT’s dividend payout ratio (DPR) is 204.08%.

Insider Activity at American Healthcare REIT

In other news, Director Scott Estes sold 2,500 shares of the business’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $59.32, for a total transaction of $148,300.00. Following the transaction, the director directly owned 18,989 shares in the company, valued at $1,126,427.48. The trade was a 11.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Mark Foster sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $55.39, for a total value of $110,780.00. Following the completion of the sale, the executive vice president owned 51,617 shares of the company’s stock, valued at $2,859,065.63. This trade represents a 3.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 6,000 shares of company stock worth $337,170. Insiders own 0.75% of the company’s stock.

Institutional Trading of American Healthcare REIT

Hedge funds and other institutional investors have recently modified their holdings of the stock. Advisors Asset Management Inc. acquired a new position in American Healthcare REIT in the 3rd quarter valued at about $337,000. Private Advisor Group LLC increased its holdings in shares of American Healthcare REIT by 15.7% during the 3rd quarter. Private Advisor Group LLC now owns 32,586 shares of the company’s stock worth $1,670,000 after buying an additional 4,431 shares during the last quarter. Ieq Capital LLC purchased a new stake in shares of American Healthcare REIT during the 3rd quarter valued at approximately $206,000. Landscape Capital Management L.L.C. purchased a new stake in shares of American Healthcare REIT during the 3rd quarter valued at approximately $6,831,000. Finally, Composition Wealth LLC raised its position in shares of American Healthcare REIT by 5.0% during the 3rd quarter. Composition Wealth LLC now owns 4,662 shares of the company’s stock valued at $239,000 after buying an additional 224 shares during the period. 16.68% of the stock is owned by institutional investors and hedge funds.

American Healthcare REIT Company Profile

(Get Free Report)

American Healthcare REIT is a real estate investment trust focused on healthcare-related properties. Its portfolio includes senior housing and care communities, skilled nursing facilities, outpatient medical buildings, and integrated senior health campuses. The company owns and operates properties across the United States and the United Kingdom. Its facilities support a range of healthcare and senior living services, including assisted living, memory care, and post-acute care. American Healthcare REIT began trading on the New York Stock Exchange in 2024.